Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb 19;21(2):241.
doi: 10.3390/molecules21020241.

Discovery of a New Class of Sortase A Transpeptidase Inhibitors to Tackle Gram-Positive Pathogens: 2-(2-Phenylhydrazinylidene)alkanoic Acids and Related Derivatives

Affiliations

Discovery of a New Class of Sortase A Transpeptidase Inhibitors to Tackle Gram-Positive Pathogens: 2-(2-Phenylhydrazinylidene)alkanoic Acids and Related Derivatives

Benedetta Maggio et al. Molecules. .

Abstract

A FRET-based random screening assay was used to generate hit compounds as sortase A inhibitors that allowed us to identify ethyl 3-oxo-2-(2-phenylhydrazinylidene)butanoate as an example of a new class of sortase A inhibitors. Other analogues were generated by changing the ethoxycarbonyl function for a carboxy, cyano or amide group, or introducing substituents in the phenyl ring of the ester and acid derivatives. The most active derivative found was 3-oxo-2-(2-(3,4dichlorophenyl)hydrazinylidene)butanoic acid (2b), showing an IC50 value of 50 µM. For a preliminary assessment of their antivirulence properties the new derivatives were tested for their antibiofilm activity. The most active compound resulted 2a, which showed inhibition of about 60% against S. aureus ATCC 29213, S. aureus ATCC 25923, S. aureus ATCC 6538 and S. epidermidis RP62A at a screening concentration of 100 µM.

Keywords: 2-(2-phenylhydrazinylidene)alkanoic acid derivatives; FRET; biofilms; sortase A.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Structure of phenylhydrazinylidene derivatives 1a and 2.
Scheme 1
Scheme 1
Synthetic route for compounds 1ah, 5ah, 6a and 7a.
Figure 2
Figure 2
Reported NH chemical shift values of the geometrical structures of compounds 1a,f, ethyl (2-phenylhydrazinylidene)mesoxalate (8) and 2-(2-phenylhydrazinylidene)propanedinitrile (9).
Figure 3
Figure 3
Dimeric structure 10 of (2E)-3-oxo-2-(2-phenylhydrazinylidene)butanenitrile (6a) and structures of (2Z)-3-oxo-2-(2-phenylazohydrazinylidene)butanamide 7a and (2Z)-acids 5ah.

Similar articles

Cited by

References

    1. World Health Organization Combat Antimicrobial Resistance. [(accessed on 16 October 2015)]. Available online: http://www.who.int/world-health-day/2011/WHD201_FS_EN.pdf.
    1. Lowy F.D. Staphylococcus aureus infections. Engl. J. Med. 1998;339:520–532. doi: 10.1056/NEJM199808203390806. - DOI - PubMed
    1. Tang Y.-W., Stratton C.W. Staphylococcus aureus: An old pathogen with new weapons. Clin. Lab. Med. 2010;30:179–208. doi: 10.1016/j.cll.2010.01.005. - DOI - PubMed
    1. Scott J.R., Barnett T.C. Surface proteins of Gram-positive bacteria and how they get there. Annu. Rev. Microbiol. 2006;60:397–423. doi: 10.1146/annurev.micro.60.080805.142256. - DOI - PubMed
    1. Høiby N., Bjarnsholt T., Givskov M., Molin S., Ciofu O. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents. 2010;35:322–332. doi: 10.1016/j.ijantimicag.2009.12.011. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources